These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 6800179

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T, Battista R, Dini E.
    Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
    [No Abstract] [Full Text] [Related]

  • 23. Studies on the phagocytic activity of neutrophilic leukocytes.
    Brandt L.
    Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
    [No Abstract] [Full Text] [Related]

  • 24. Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.
    Cortellazzo S, Viero P, Buczko W, Barbui T, de Gaetano G.
    Scand J Haematol; 1985 Feb; 34(2):146-51. PubMed ID: 3856312
    [Abstract] [Full Text] [Related]

  • 25. Platelets in the myeloproliferative syndrome.
    Weinfeld A, Branehög I, Kutti J.
    Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases.
    Tinggaard Pedersen N, Laursen B.
    Scand J Haematol; 1983 Jan; 30(1):50-8. PubMed ID: 6573016
    [Abstract] [Full Text] [Related]

  • 32. [Secondary hyperuricemia in hemoblastosis].
    Richter R, Hermanny G, Hofer E, Stobbe H.
    Dtsch Gesundheitsw; 1971 Nov 04; 26(45):2126-30. PubMed ID: 5145658
    [No Abstract] [Full Text] [Related]

  • 33. Hypocholesterolemia in myeloproliferative disorders.
    Spanos GA, Bajaj K, Rosner F.
    Arch Intern Med; 1981 Jan 04; 141(1):137-8. PubMed ID: 6934710
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Phagocytosis in myeloproliferative disorders.
    Corberand J, LaHarrague P, De Larrard B, Nguyen F, Pris J.
    Am J Clin Pathol; 1980 Sep 04; 74(3):301-5. PubMed ID: 6932175
    [Abstract] [Full Text] [Related]

  • 36. [Reduced glutathione (GSH) in erythrocytes in myeloproliferative diseases].
    Benöhr HC, Tigges FJ, Waller HD.
    Verh Dtsch Ges Inn Med; 1973 Sep 04; 79():461-3. PubMed ID: 4790261
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Familial myeloproliferative syndromes. Study of 6 families and review of literature].
    Kaufman S, Brière J, Bernard J.
    Nouv Rev Fr Hematol (1978); 1978 Apr 14; 20(1):1-15. PubMed ID: 353725
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders.
    Pareti FI, Gugliotta L, Mannucci L, Guarini A, Mannucci PM.
    Thromb Haemost; 1982 Apr 30; 47(2):84-9. PubMed ID: 7101243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.